{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:38:34Z","timestamp":1792805914406,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.lungcan.2009.03.016","type":"journal-article","created":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T08:36:16Z","timestamp":1240216576000},"page":"57-68","source":"Crossref","is-referenced-by-count":56,"title":["Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets"],"prefix":"10.1016","volume":"67","author":[{"given":"Oluf Dimitri","family":"R\u00f8e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endre","family":"Anderssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Sandeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinar","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2009.03.016_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2009.03.016_bib2","first-page":"32","article-title":"Peritoneal mesothelioma: a review","volume":"9","author":"Bridda","year":"2007","journal-title":"Med Gen Med"},{"issue":"Suppl. 1","key":"10.1016\/j.lungcan.2009.03.016_bib3","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.lungcan.2005.03.013","article-title":"Chemotherapy for malignant mesothelioma","volume":"49","author":"Baas","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib4","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib5","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/bioinformatics\/btf877","article-title":"Identifying differentially expressed genes using false discovery rate controlling procedures","volume":"19","author":"Reiner","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.lungcan.2009.03.016_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.lungcan.2009.03.016_bib8","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkm882","article-title":"KEGG for linking genomes to life and the environment","volume":"36","author":"Kanehisa","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.lungcan.2009.03.016_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1471-2105-8-346","article-title":"A framework for significance analysis of gene expression data using dimension reduction methods","volume":"8","author":"Gidskehaug","year":"2007","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.lungcan.2009.03.016_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V","article-title":"Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis","volume":"72","author":"Boutin","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy","volume":"44","author":"Hassan","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib13","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1183\/09031936.96.09122565","article-title":"Effect of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesotheliomas: a nonrandomized phase II study","volume":"9","author":"Linden","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lungcan.2009.03.016_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.bjc.6604421","article-title":"Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma","volume":"99","author":"Sorensen","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib15","first-page":"96","article-title":"Taxanes, microtubules and chemoresistant breast cancer","volume":"1785","author":"McGrogan","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.lungcan.2009.03.016_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cancergencyto.2006.11.012","article-title":"Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer","volume":"174","author":"Yamamoto","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.lungcan.2009.03.016_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI23412","article-title":"Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer","volume":"115","author":"Glinsky","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lungcan.2009.03.016_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ceb.2006.08.015","article-title":"The case for survivin as a regulator of microtubule dynamics and cell-death decisions","volume":"18","author":"Altieri","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/0008-5472.CAN-07-5279","article-title":"Tumor cell dependence on Ran-GTP-directed mitosis","volume":"68","author":"Xia","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1083\/jcb.123.4.849","article-title":"Cytoplasmic dynein plays a role in mammalian mitotic spindle formation","volume":"123","author":"Vaisberg","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00401-006-0180-7","article-title":"Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation","volume":"113","author":"Suzuki","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng1352","article-title":"The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression","volume":"36","author":"Kim","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.lungcan.2009.03.016_bib23","doi-asserted-by":"crossref","first-page":"11569","DOI":"10.1074\/jbc.M413471200","article-title":"Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells","volume":"280","author":"Marcus","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2009.03.016_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.gt.3302595","article-title":"RNA interference against Hec1 inhibits tumor growth in vivo","volume":"13","author":"Gurzov","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.lungcan.2009.03.016_bib25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1242\/jcs.000604","article-title":"Hsp90 is required to localise cyclin B and Msps\/ch-TOG to the mitotic spindle in Drosophila and humans","volume":"120","author":"Basto","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.lungcan.2009.03.016_bib26","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/0008-5472.CAN-06-3871","article-title":"Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1\/Akt pathway","volume":"67","author":"Pespeni","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib27","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4161\/cc.6367","article-title":"FERM control of FAK function: implications for cancer therapy","volume":"7","author":"Lim","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lungcan.2009.03.016_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1158\/1078-0432.CCR-07-2220","article-title":"Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention","volume":"14","author":"Parsons","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib29","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1158\/1078-0432.CCR-05-1728","article-title":"Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells","volume":"11","author":"Halder","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib30","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1038\/sj.onc.1206946","article-title":"Resistance to antifolates","volume":"22","author":"Zhao","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2009.03.016_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10637-007-9060-9","article-title":"In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression","volume":"25","author":"Hanauske","year":"2007","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.lungcan.2009.03.016_bib32","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/cncr.23491","article-title":"Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer","volume":"112","author":"Zheng","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib33","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1093\/nar\/gkh872","article-title":"Repair of U\/G and U\/A in DNA by UNG2-associated repair complexes takes place predominantly by short-patch repair both in proliferating and growth-arrested cells","volume":"32","author":"Akbari","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bcp.2008.05.019","article-title":"Uracil in DNA: consequences for carcinogenesis and chemotherapy","volume":"76","author":"Berger","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib35","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/sj.bjc.6604344","article-title":"Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel\/gemcitabine","volume":"98","author":"Souglakos","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib36","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1038\/sj.onc.1206935","article-title":"Mechanisms of resistance to topoisomerase I-targeting drugs","volume":"22","author":"Rasheed","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2009.03.016_bib37","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1074\/jbc.M106287200","article-title":"S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function","volume":"277","author":"Cliby","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2009.03.016_bib38","first-page":"3535","article-title":"Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition","volume":"61","author":"Cusack","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mrfmmm.2007.09.005","article-title":"DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair","volume":"638","author":"Spencer","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000055914","article-title":"DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer","volume":"68","author":"Nakopoulou","year":"2000","journal-title":"Pathobiology"},{"issue":"Suppl. 2","key":"10.1016\/j.lungcan.2009.03.016_bib41","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.breast.2007.07.021","article-title":"Using specific cytotoxics with a targeted mind","volume":"16","author":"Di Leo","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.lungcan.2009.03.016_bib42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/02841860801995396","article-title":"The value of TOP2A gene copy number variation as a biomarker in breast cancer: update of DBCG trial 89D","volume":"47","author":"Vang Nielsen","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1752-699X.2008.00050.x","article-title":"Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic study","volume":"2","author":"Hillerdal","year":"2008","journal-title":"Clin Respir J"},{"key":"10.1016\/j.lungcan.2009.03.016_bib44","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.1985.3.11.1529","article-title":"Detorubicin\u2014an active anthracycline in untreated metastatic melanoma","volume":"3","author":"Chawla","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib45","first-page":"22","article-title":"Malignant pleural mesothelioma treated with a combination of pegylated liposomal doxorubicin, carboplatin and gemcitabine: The CCG study","author":"Hillerdal","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2007.02.001","article-title":"Mechanisms of resistance to cisplatin and carboplatin","volume":"63","author":"Stewart","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0026-895X(25)10499-9","article-title":"Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines","volume":"48","author":"Beall","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib48","first-page":"6414","article-title":"Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma","volume":"62","author":"Hassan","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2007.09.022","article-title":"NF-kappa B-mediated adaptive resistance to ionizing radiation","volume":"44","author":"Ahmed","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.lungcan.2009.03.016_bib50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00066-007-1800-4","article-title":"The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target","volume":"183","author":"Capalbo","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2009.03.016_bib52","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.yexcr.2006.06.014","article-title":"The Fanconi anemia\/BRCA pathway: a coordinator of cross-link repair","volume":"312","author":"Mirchandani","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib53","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1200\/JCO.2005.05.4171","article-title":"DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes","volume":"24","author":"Kennedy","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib54","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1535-7163.MCT-05-0493","article-title":"Chemosensitization to cisplatin by inhibitors of the Fanconi anemia\/BRCA pathway","volume":"5","author":"Chirnomas","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.lungcan.2009.03.016_bib55","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1093\/nar\/gkg753","article-title":"Vanillins\u2014a novel family of DNA-PK inhibitors","volume":"31","author":"Durant","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1349-7006.2008.00741.x","article-title":"Down regulation of BRCA2 causes radio-sensitization of human tumor cells in vitro and in vivo","volume":"99","author":"Yu","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.lungcan.2009.03.016_bib57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-8140(01)00370-X","article-title":"Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity","volume":"60","author":"Marcou","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib58","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1093\/emboj\/20.23.6660","article-title":"Fission yeast Rad50 stimulates sister chromatid recombination and links cohesion with repair","volume":"20","author":"Hartsuiker","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.lungcan.2009.03.016_bib59","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1158\/0008-5472.CAN-07-1015","article-title":"Proteasome function is required for DNA damage response and fanconi anemia pathway activation","volume":"67","author":"Jacquemont","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1667\/RR0459.1","article-title":"Isolation and characterization of a novel human radiosusceptibility gene, NP95","volume":"166","author":"Muto","year":"2006","journal-title":"Radiat Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib61","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.onc.1210700","article-title":"High expression of DNA repair pathways is associated with metastasis in melanoma patients","volume":"27","author":"Kauffmann","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2009.03.016_bib62","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","article-title":"Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer","volume":"365","author":"Wang","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2009.03.016_bib63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng1061","article-title":"Identifying distinct classes of bladder carcinoma using microarrays","volume":"33","author":"Dyrskjot","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.lungcan.2009.03.016_bib64","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/sj.onc.1201143","article-title":"Inactivation of p53 results in high rates of homologous recombination","volume":"14","author":"Mekeel","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2009.03.016_bib65","doi-asserted-by":"crossref","first-page":"37765","DOI":"10.1074\/jbc.M204177200","article-title":"CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53","volume":"277","author":"Hasan","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2009.03.016_bib66","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-07-5472","article-title":"Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance","volume":"68","author":"Chan","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib67","first-page":"2429","article-title":"Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs","volume":"60","author":"Ogiso","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib68","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.onc.1209809","article-title":"Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors","volume":"26","author":"Borczuk","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2009.03.016_bib69","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1158\/1078-0432.CCR-07-0536","article-title":"Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma","volume":"13","author":"Sartore-Bianchi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.lungcan.2004.10.005","article-title":"Thalidomide in patients with malignant pleural mesothelioma","volume":"48","author":"Baas","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/157489207780832478","article-title":"Thalidomide analogues as anticancer drugs","volume":"2","author":"Aragon-Ching","year":"2007","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"10.1016\/j.lungcan.2009.03.016_bib72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(03)00224-2","article-title":"The unfolding tale of PECAM-1","volume":"540","author":"Jackson","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.lungcan.2009.03.016_bib73","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1084\/jem.20060565","article-title":"ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability","volume":"203","author":"Wegmann","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.lungcan.2009.03.016_bib74","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.0022-202X.2005.23912.x","article-title":"Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation","volume":"125","author":"Ludwig","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jtcvs.2003.08.034","article-title":"Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma","volume":"127","author":"Kruklitis","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2009.03.016_bib76","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1074\/jbc.275.8.5416","article-title":"NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity","volume":"275","author":"Pink","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2009.03.016_bib77","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1479-7364-1-6-460","article-title":"Analysis of the glutathione S-transferase (GST) gene family","volume":"1","author":"Nebert","year":"2004","journal-title":"Hum Genom"},{"key":"10.1016\/j.lungcan.2009.03.016_bib78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clpt.2006.08.013","article-title":"Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine","volume":"80","author":"Oscarson","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lungcan.2009.03.016_bib79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.bjc.6604208","article-title":"G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer","volume":"98","author":"Bucher","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib80","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ymthe.2005.12.009","article-title":"Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus","volume":"13","author":"Gao","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.lungcan.2009.03.016_bib81","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00280-007-0539-z","article-title":"Caffeine markedly sensitizes human mesothelioma cell lines to pemetrexed","volume":"61","author":"Min","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lungcan.2009.03.016_bib82","first-page":"20","article-title":"A gene-centric human protein atlas for expression profiles based on antibodies","author":"Berglund","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.lungcan.2009.03.016_bib83","first-page":"83","article-title":"The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer","volume":"25","author":"Ozdemir","year":"2006","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib84","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.03.016_bib85","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature02320","article-title":"Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome","volume":"427","author":"Tian","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2009.03.016_bib86","first-page":"607","article-title":"Dose-dependent expression changes of early response genes to ionizing radiation in human lymphoblastoid cells","volume":"19","author":"Long","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.lungcan.2009.03.016_bib87","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1073\/pnas.0538044100","article-title":"Selective killing of cancer cells by beta-lapachone: direct checkpoint activation as a strategy against cancer","volume":"100","author":"Li","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2009.03.016_bib88","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00428-005-0132-y","article-title":"Correlation of invasion and metastasis of cancer cells, and expression of the RAD21 gene in oral squamous cell carcinoma","volume":"448","author":"Yamamoto","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.lungcan.2009.03.016_bib89","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1535-7163.MCT-04-0241","article-title":"Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells","volume":"4","author":"Atienza","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.lungcan.2009.03.016_bib90","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Lopez-Rios","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib91","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4161\/cc.5.11.2796","article-title":"Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway","volume":"5","author":"Glinsky","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lungcan.2009.03.016_bib92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mrrev.2007.12.002","article-title":"Overexpression of DNA repair genes is associated with metastasis: a new hypothesis","volume":"659","author":"Sarasin","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.lungcan.2009.03.016_bib93","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1470-2045(08)70029-9","article-title":"Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?","volume":"9","author":"Seve","year":"2008","journal-title":"Lancet Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500209001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500209001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T02:41:25Z","timestamp":1739068885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500209001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0169500209001391"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2009.03.016","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}